155 related articles for article (PubMed ID: 31114278)
1. Progressive reduction in skeletal muscle mass to visceral fat area ratio is associated with a worsening of the hepatic conditions of non-alcoholic fatty liver disease.
Shida T; Oshida N; Oh S; Okada K; Shoda J
Diabetes Metab Syndr Obes; 2019; 12():495-503. PubMed ID: 31114278
[No Abstract] [Full Text] [Related]
2. Skeletal muscle mass to visceral fat area ratio is an important determinant affecting hepatic conditions of non-alcoholic fatty liver disease.
Shida T; Akiyama K; Oh S; Sawai A; Isobe T; Okamoto Y; Ishige K; Mizokami Y; Yamagata K; Onizawa K; Tanaka H; Iijima H; Shoda J
J Gastroenterol; 2018 Apr; 53(4):535-547. PubMed ID: 28791501
[TBL] [Abstract][Full Text] [Related]
3. Appendicular Skeletal Muscle Mass to Visceral Fat Area Ratio Predicts Hepatic Morbidities.
Han E; Lee YH; Ahn SH; Cha BS; Kim SU; Lee BW
Gut Liver; 2024 May; 18(3):509-519. PubMed ID: 38013477
[TBL] [Abstract][Full Text] [Related]
4. The relationship between non-alcoholic fatty liver and skeletal muscle mass to visceral fat area ratio in women with type 2 diabetes.
Su X; Xu J; Zheng C
BMC Endocr Disord; 2019 Jul; 19(1):76. PubMed ID: 31315613
[TBL] [Abstract][Full Text] [Related]
5. Skeletal muscle mass to visceral fat area ratio as a predictor of NAFLD in lean and overweight men and women with effect modification by sex.
Cho Y; Chang Y; Ryu S; Jung HS; Kim CW; Oh H; Kim MK; Sohn W; Shin H; Wild SH; Byrne CD
Hepatol Commun; 2022 Sep; 6(9):2238-2252. PubMed ID: 35503803
[TBL] [Abstract][Full Text] [Related]
6. Clinical and anthropometric characteristics of non-obese non-alcoholic fatty liver disease subjects in Japan.
Shida T; Oshida N; Suzuki H; Okada K; Watahiki T; Oh S; Kim T; Isobe T; Okamoto Y; Ariizumi SI; Yamamoto M; Shoda J
Hepatol Res; 2020 Sep; 50(9):1032-1046. PubMed ID: 32602214
[TBL] [Abstract][Full Text] [Related]
7. The relationship between skeletal muscle mass to visceral fat area ratio and metabolic dysfunction-associated fatty liver disease subtypes in middle-aged and elderly population: a single-center retrospective study.
Xing M; Ni Y; Zhang Y; Zhao X; Yu X
Front Nutr; 2023; 10():1246157. PubMed ID: 38024359
[TBL] [Abstract][Full Text] [Related]
8. Reduction of Fat to Muscle Mass Ratio Is Associated with Improvement of Liver Stiffness in Diabetic Patients with Non-Alcoholic Fatty Liver Disease.
Osaka T; Hashimoto Y; Okamura T; Fukuda T; Yamazaki M; Hamaguchi M; Fukui M
J Clin Med; 2019 Dec; 8(12):. PubMed ID: 31835362
[TBL] [Abstract][Full Text] [Related]
9. The Leg Fat to Total Fat Ratio Is Associated with Lower Risks of Non-Alcoholic Fatty Liver Disease and Less Severe Hepatic Fibrosis: Results from Nationwide Surveys (KNHANES 2008-2011).
Kim HM; Lee YH
Endocrinol Metab (Seoul); 2021 Dec; 36(6):1232-1242. PubMed ID: 34809412
[TBL] [Abstract][Full Text] [Related]
10. Association of non-alcoholic steatohepatitis with subclinical myocardial dysfunction in non-cirrhotic patients.
Lee YH; Kim KJ; Yoo ME; Kim G; Yoon HJ; Jo K; Youn JC; Yun M; Park JY; Shim CY; Lee BW; Kang SM; Ha JW; Cha BS; Kang ES
J Hepatol; 2018 Apr; 68(4):764-772. PubMed ID: 29175242
[TBL] [Abstract][Full Text] [Related]
11. Association Between Skeletal Muscle Mass and Severity of Steatosis and Fibrosis in Non-alcoholic Fatty Liver Disease.
Guo W; Zhao X; Miao M; Liang X; Li X; Qin P; Lu J; Zhu W; Wu J; Zhu C; Xu N; Zhang Q
Front Nutr; 2022; 9():883015. PubMed ID: 35558748
[TBL] [Abstract][Full Text] [Related]
12. Lifestyle predictors of obese and non-obese patients with nonalcoholic fatty liver disease: A cross-sectional study.
Kwak JH; Jun DW; Lee SM; Cho YK; Lee KN; Lee HL; Lee OY; Choi HS; Yoon BC
Clin Nutr; 2018 Oct; 37(5):1550-1557. PubMed ID: 28918170
[TBL] [Abstract][Full Text] [Related]
13. Increase in the skeletal muscle mass to body fat mass ratio predicts the decline in transaminase in patients with nonalcoholic fatty liver disease.
Mizuno N; Seko Y; Kataoka S; Okuda K; Furuta M; Takemura M; Taketani H; Hara T; Umemura A; Nishikawa T; Yamaguchi K; Moriguchi M; Itoh Y
J Gastroenterol; 2019 Feb; 54(2):160-170. PubMed ID: 29948305
[TBL] [Abstract][Full Text] [Related]
14. Visceral adiposity as a risk factor for lean non-alcoholic fatty liver disease in potential living liver donors.
Lee S; Kim KW; Lee J; Park T; Khang S; Jeong H; Song GW; Lee SG
J Gastroenterol Hepatol; 2021 Nov; 36(11):3212-3218. PubMed ID: 34169561
[TBL] [Abstract][Full Text] [Related]
15. Age-related fat deposition in multifidus muscle could be a marker for nonalcoholic fatty liver disease.
Kitajima Y; Eguchi Y; Ishibashi E; Nakashita S; Aoki S; Toda S; Mizuta T; Ozaki I; Ono N; Eguchi T; Arai K; Iwakiri R; Fujimoto K
J Gastroenterol; 2010 Feb; 45(2):218-24. PubMed ID: 19882375
[TBL] [Abstract][Full Text] [Related]
16. The role of skeletal muscle in development of nonalcoholic Fatty liver disease.
Moon JS; Yoon JS; Won KC; Lee HW
Diabetes Metab J; 2013 Aug; 37(4):278-85. PubMed ID: 23991406
[TBL] [Abstract][Full Text] [Related]
17. Relationship between body composition and the histology of non-alcoholic fatty liver disease: a cross-sectional study.
Miyake T; Miyazaki M; Yoshida O; Kanzaki S; Nakaguchi H; Nakamura Y; Watanabe T; Yamamoto Y; Koizumi Y; Tokumoto Y; Hirooka M; Furukawa S; Takeshita E; Kumagi T; Ikeda Y; Abe M; Toshimitsu K; Matsuura B; Hiasa Y
BMC Gastroenterol; 2021 Apr; 21(1):170. PubMed ID: 33849437
[TBL] [Abstract][Full Text] [Related]
18. [Acupuncture improves hepatic lipid metabolism by suppressing oxidative stress in obese nonalcoholic fatty liver disease rats].
Wang HY; Liang CM; Cui JW; Pan L; Hu H; Fang HJ
Zhen Ci Yan Jiu; 2019 Mar; 44(3):189-94. PubMed ID: 30945501
[TBL] [Abstract][Full Text] [Related]
19. Age-Related Decrease in Skeletal Muscle Mass Is an Independent Risk Factor for Incident Nonalcoholic Fatty Liver Disease: A 10-Year Retrospective Cohort Study.
Lee MJ; Kim EH; Bae SJ; Kim GA; Park SW; Choe J; Jung CH; Lee WJ; Kim HK
Gut Liver; 2019 Jan; 13(1):67-76. PubMed ID: 30037166
[TBL] [Abstract][Full Text] [Related]
20. Whole-body substrate metabolism is associated with disease severity in patients with non-alcoholic fatty liver disease.
Croci I; Byrne NM; Choquette S; Hills AP; Chachay VS; Clouston AD; O'Moore-Sullivan TM; Macdonald GA; Prins JB; Hickman IJ
Gut; 2013 Nov; 62(11):1625-33. PubMed ID: 23077135
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
